Response to Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217

Affiliations

¹ Department of Human Biology and Human Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
² Department of Human Biology and Human Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands p.schrauwen@maastrichtuniversity.nl.

Comment

Marlies de Ligt et al. Diabetes Care. 2017 Sep.

. 2017 Sep;40(9):e134.

doi: 10.2337/dci17-0019.

¹ Department of Human Biology and Human Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
² Department of Human Biology and Human Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands p.schrauwen@maastrichtuniversity.nl.

No abstract available

Comment on

Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial.
Timmers S, de Ligt M, Phielix E, van de Weijer T, Hansen J, Moonen-Kornips E, Schaart G, Kunz I, Hesselink MK, Schrauwen-Hinderling VB, Schrauwen P. Timmers S, et al. Diabetes Care. 2016 Dec;39(12):2211-2217. doi: 10.2337/dc16-0499. Epub 2016 Oct 6. Diabetes Care. 2016. PMID: 27852684 Clinical Trial.
Comment on Timmers et al. Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2016;39:2211-2217.
Méndez-Del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG. Méndez-Del Villar M, et al. Diabetes Care. 2017 Sep;40(9):e133. doi: 10.2337/dc17-0465. Diabetes Care. 2017. PMID: 28830966 No abstract available.